Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07690761 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant

Study acronym: Rituximab+ Zan
StatusEnrolling by Invitation
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
investigators propose a phase II, open label-nonrandomized, single arm, multicenter study aiming to assess the safety and efficacy with the combination of Rituximab and Zanubrutinib in patients with HAIRY CELL LUKEMIA HCL, or HAIRY CELL LEUKEMIA VARIANT-HCLv.
Trial Details
NCT Number NCT07690761
Lead Sponsor Bnai Zion Medical Center
Collaborators: Meir Medical Center, Hadassah Medical Organization
Conditions
(from sponsor)		 Hairy Cell Leukemia, Hairy Cell Leukemia Variant
Related terms Leukemia, Hairy Cell
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov